Not Nvidia. Not Micron. After the Chip Sell-Off, I'd Buy This AI Stock and Hold It Forever.

Semiconductor stocks have fallen about 30% since Oct. 6, while TSMC has grown to 73% of contract semiconductor manufacturing spend. Management guided to $60B–$64B in capex this year, following $40.9B in 2025 and $29.8B in 2024, and expects continued increases; TSMC reported 35.9% sales growth in 2025 and its 2024–2029 revenue-growth guidance was 25% annually. The article argues that TSMC’s roughly 21x forward earnings multiple is attractive given expected revenue growth above 20% and its leading foundry position.

Analysis

TSMC’s strategic value is less a bet on which AI chip designer wins than on continued outsourcing to leading-edge foundries. That diversification can support a relative-quality premium, but it does not insulate TSM from a pause in hyperscaler spending: delayed customer orders would hit utilization and returns on a rapidly expanding capital base. The key second-order risk is overcapacity—if planned fabs arrive after AI demand cools, depreciation can pressure margins before revenue catches up. Samsung and Intel could also narrow the process gap, though the article provides no evidence that this is imminent.

Treat the article’s growth, capex and valuation figures as claims to verify against company filings and guidance, not as a standalone valuation case. Near term, sentiment and AI-capex headlines may dominate. Over 1–3 months, watch TSM’s guidance, advanced-node utilization and customer order revisions; over 6–18 months, the test is whether capacity additions earn adequate returns without margin deterioration. Taiwan geopolitical risk is a distinct, potentially discontinuous downside that a relative valuation does not hedge.

The contrarian opportunity is relative, not absolute: TSM could be the more resilient AI exposure, but a 21x forward multiple is not automatically cheap if growth expectations or capex returns reset. MU’s commodity-cycle discount also may understate memory demand from AI; the cited 2029 supply risk is a longer-dated thesis, not a near-term short catalyst.

Key Decisions for Investors

• Consider a staged long in TSM rather than buying the sector indiscriminately; add only if company guidance and reported utilization support the growth-and-return-on-capex thesis. Size for Taiwan event risk.
• Prefer TSM over MU on a relative basis, but do not establish a large outright MU short solely on the article’s 2029 supply forecast. Reassess as new capacity and memory pricing data arrive.
• Falsify the TSM thesis if management cuts demand or revenue expectations, advanced-node utilization weakens, or capex rises while margin and cash-generation trends deteriorate. Verify these against filings and earnings calls.
• Use hyperscaler capex revisions and Taiwan-related escalation as risk triggers; either could overwhelm company-specific execution in the near term.